Artis BioSolutions
Lake Nona, FL
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
59.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (5)
○ EMA GMP
○ MHRA GMP
Quick Facts: Artis BioSolutions
- Signal Score
- 59.0/100 (as of 2026-04-02)
- Quality Compliance
- Assessment pending
- Headquarters
- Lake Nona, FL
- Modalities
- Cell Therapy, CAR-T
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy, CAR-T
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Lake Nona, FL
Modalities: Cell Therapy, CAR-T
Capacity assessment: 58.0/100
Sites: Lake Nona, FL
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press5 articles
1 manufacturing site: Lake Nona, FL
Modalities: Cell Therapy, CAR-T
Capacity assessment: 58.0/100
Recent News 5 articles
Synthetic DNA Manufacturing Hub Set Up in Boston by Artis BioSolutions - Genetic Engineering and Biotechnology News
Synthetic DNA Manufacturing Hub Set Up in Boston by Artis BioSolutions genengnews.com
Artis BioSolutions Establishes Synthetic DNA Mfg. Hub in Boston - Contract Pharma
Artis BioSolutions Establishes Synthetic DNA Mfg. Hub in Boston Contract Pharma
Artis BioSolutions Expands with New Synthetic DNA Manufacturing Capabilities in Boston - citybiz
Artis BioSolutions Expands with New Synthetic DNA Manufacturing Capabilities in Boston citybiz
Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston - Business Wire
Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston Business Wire
Artis BioSolutions Appoints Dr. Kate Broderick, Ph.D., as Chief Scientific Innovation Officer to Advance Synthetic DNA Strategy - Business Wire
Artis BioSolutions Appoints Dr. Kate Broderick, Ph.D., as Chief Scientific Innovation Officer to Advance Synthetic DNA Strategy Business Wire
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 90.7
CAR-T, Cell Therapy
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 84.9
CAR-T, Cell Therapy
Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.5
CAR-T, Cell Therapy
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 82.9
CAR-T, Cell Therapy, AAV